Par Drugs and Chemicals (NSE:PAR) Total Assets: ₹1,292 Mil (As of Mar. 2026)


NSE:PAR Par Drugs and Chemicals Ltd NSE:PAR
81 GF Score
Price ₹89.58
GF Value ₹207.86
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Par Drugs and Chemicals Total Assets?

Par Drugs and Chemicals NSE:PAR -0.04% 81 Total Assets is ₹1,292 Mil as of Mar. 2026. GuruFocus rates NSE:PAR with a GF Score™ of 81/100 and a GF Value™ of ₹207.86 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Par Drugs and Chemicals's Total Assets for the quarter that ended in Mar. 2026 was ₹1,292 Mil.

During the past 12 months, Par Drugs and Chemicals's average Total Assets Growth Rate was -4.80% per year. During the past 3 years, the average Total Assets Growth Rate was 9.50% per year. During the past 5 years, the average Total Assets Growth Rate was 10.30% per year.

During the past 10 years, Par Drugs and Chemicals's highest 3-Year average Total Assets Growth Rate was 13.70%. The lowest was -2.00%. And the median was 6.80%.

Total Assets is connected with ROA %. Par Drugs and Chemicals's annualized ROA % for the quarter that ended in Mar. 2026 was 2.64%. Total Assets is also linked to Revenue through Asset Turnover. Par Drugs and Chemicals's Asset Turnover for the quarter that ended in Mar. 2026 was 0.15.

Par Drugs and Chemicals  (NSE:PAR) Total Assets Explanation

Total Assets is connected with ROA %.

Par Drugs and Chemicals's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=34.144/( (0+1292.123)/ 1 )
=34.144/1292.123
=2.64 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Par Drugs and Chemicals's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=196.108/( (0+1292.123)/ 1 )
=196.108/1292.123
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Par Drugs and Chemicals Total Assets Related Terms

Par Drugs and Chemicals Total Assets Historical Data

* Premium members only.

The historical data trend for Par Drugs and Chemicals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Par Drugs and Chemicals Total Assets Chart

Par Drugs and Chemicals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 786.90 888.68 1,016.11 1,193.90 1,292.12

Par Drugs and Chemicals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,193.90 0.00 1,275.24 0.00 1,292.12
NSE:PAR
81GF Score
Par Drugs and Chemicals Ltd NSE:PAR
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Par Drugs and Chemicals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Par Drugs and Chemicals's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (A: Mar. 2026 )+Total Liabilities (A: Mar. 2026 )
=1119.846+172.277
=1,292

Par Drugs and Chemicals's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=1119.846+172.277
=1,292

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of ₹1,292 Mil mean?
Par Drugs and Chemicals (NSE:PAR) has a Total Assets of ₹1,292 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Par Drugs and Chemicals and its competitors.
Is Par Drugs and Chemicals' Total Assets too high?
Par Drugs and Chemicals' current Total Assets is ₹1,292 Mil. Overall, Par Drugs and Chemicals has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Par Drugs and Chemicals' Total Assets compare to ZTS and UTHR?
Par Drugs and Chemicals' Total Assets of ₹1,292 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Par Drugs and Chemicals and its competitors. Par Drugs and Chemicals's current Total Assets is ₹1,292 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Par Drugs and Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Par Drugs and Chemicals (NSE:PAR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹207.86, compared to a current price of ₹89.58 — trading 56.9% below its estimated fair value. The current Total Assets is ₹1,292 Mil. Par Drugs and Chemicals' overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Par Drugs and Chemicals (NSE:PAR), the current Total Assets is ₹1,292 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Par Drugs and Chemicals (NSE:PAR) Overvalued in 2026?

Based on GuruFocus' analysis, Par Drugs and Chemicals stock appears to be undervalued. The current stock price of ₹89.58 is trading 56.9% below its estimated GF Value™ of ₹207.86. GuruFocus considers Par Drugs and Chemicals to be Significantly Undervalued.

Key valuation signals for NSE:PAR:

  • Total Assets: ₹1,292 Mil
  • GF Value™: ₹207.86 vs. price of ₹89.58 (56.9% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the NSE:PAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Par Drugs and Chemicals Business Description

Address Gotri Vasna Road, 815, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd manufactures active Pharmaceutical Ingredients (APIs) and fine chemicals, serving domestic and international markets. Specializing in essential magnesium-based compounds and other specialty chemicals such as Magnesium Hydroxide, Magnesium Trisilicate, Magnesium Carbonate, various grades of Magnesium Oxide, Dried Aluminum Hydroxide Gel, and Sucralfate USP, the Company produces high-quality bulk drugs used in the formulation of finished pharmaceutical products like tablets, capsules, and liquids. Committed to maintaining stringent quality standards and utilizing manufacturing processes, the Company plays a vital role in supplying reliable ingredients that ensure the safety, efficacy, and stability of pharmaceutical formulations internationally.
81GF Score

Get the complete analysis for NSE:PAR

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹89.58
Price
₹207.86
GF Value